Filter
237
Text search:
neisseria
Featured
Recommendations
24
New Publications
66
Language
Document type
No document type
126
Guidelines
46
Studies & Reports
31
Manuals
13
Strategic & Response Plan
12
Situation Updates
6
Training Material
1
Infographics
1
Fact sheets
1
Countries / Regions
Africa
9
Nepal
8
South Africa
8
Philippines
7
India
7
Germany
6
Latin America and the Carribbean
6
Congo, Democratic Republic of
5
Tanzania
5
Paraguay
4
Ethiopia
3
Cameroon
3
Ghana
3
Rwanda
3
Bangladesh
3
Malawi
3
Argentina
3
Global
3
Liberia
2
Nigeria
2
Senegal
2
Mali
2
Uganda
2
Zimbabwe
2
Kenya
2
Mozambique
2
Central African Republic
2
Peru
2
Ukraine
2
Western and Central Europe
2
Asia
2
Burkina Faso
1
Sierra Leone
1
USA
1
Togo
1
Pakistan
1
Zambia
1
Syria
1
Thailand
1
China
1
Colombia
1
Madagascar
1
Myanmar / Burma
1
Yemen
1
West and Central Africa
1
Middle East and North Africa
1
Western Pacific Region
1
Eastern Europe and Central Asia
1
Fiji
1
Eastern Europe
1
Laos
1
Russia
1
Mauritius
1
Authors & Publishers
Publication Years
Category
Countries
73
Clinical Guidelines
29
Women & Child Health
17
Public Health
10
Pharmacy & Technologies
6
Key Resources
4
Capacity Building
1
Toolboxes
AMR
61
HIV
25
Rapid Response
21
Pharmacy
16
Mental Health
12
Refugee
7
TB
7
Ebola
5
Caregiver
4
Conflict
2
COVID-19
2
Global Health Education
1
Planetary Health
1
Prevention, early diagnosis, and effective treatment are essential for the control and elimination of Neisseria gonorrhoeae as a public health problem. Currently, in Latin America and the Caribbean, treatment for gonorrhea infection is largely empir
...
WHO/iVB.11.09
WHO manual, 2nd edition
В этой брошюре рассказывается о том, что такое бактериальный менингит (т.е. менингит,
который вызван бактериями Neisseria meningitides, Streptococcus pneumo
...
WHO Guideline. Since 2010, countries in the meningitis belt have started to introduce a new serogroup A meningococcal conjugate vaccine conferring individual protection and herd immunity. Following the successful roll-out of this vaccine, epidemics due to
...
Development of one or more vaccines for Neisseria gonorrhoeae is an important objective for sexual and reproductive health worldwide, and for the fight against antimicrobial resistance.
WHO preferred product characteristics (PPCs) provide strateg
...
WHO practical guidelines. 2nd edition
The WHO global health sector strategy on sexually
transmitted infections, 2016–2021 (1) includes country
milestones for achievement by 2020 and global
targets for achievement by 2030. In addition, countries
were called to identify national sexually transmitted
infection (STI) targets for
...
Weekly epidemiological record Relevé épidémiologique hebdomadaire 27 MARCH 2015, 90th YEAR / 27 MARS 2015, 90e ANNÉE No. 13, 2015, 90, 121–132
Despite the development of point-of-care diagnostic tests for syphilis, chlamydia, gonorrhoea, and trichomoniasis, none comply with all WHO criteria. This analysis overviews landscape analyses of point-of-care diagnostic technologies for Chlamydia trachomatis,
...
Epidemic meningitis is a major public health challenge in the African 'meningitis belt', an area that extends from Senegal to Ethiopia with an estimated total population of 500 million. Since 2002, the World Health Organization (WHO), in collaboration with its collaborating centres for meningitis, h
...
This series highlights current challenges to the management of Neisseria gonorrhoeae, Chlamydia trachomatis, Mycoplasma genitalium, non-gonococcal urethris, bacterial vaginosis, syphilis and Trichomonas vaginalis. We have assembled a collection of s
...
28 Sept. 2021
The focus of this fact sheet is on the four main causes of acute bacterial meningitis:
Neisseria meningitidis (meningococcus)
Streptococcus pneumoniae (pneumococcus)
Haemophilus influenzae
Streptococcus agalacti
...
19 février 2018
ຢາຕ້ານເຊື້ອຈຸລະຊີບ (Antimicrobial medicines) ມີຄວາມສໍາຄັນຫຼາຍຕໍ່ວຽກງານການແພດ, ສາທາລະນະສຸກ, ສຸຂະພາບສັດ ແລະ ການຜະລິດອາຫານ. ເນ
...
